These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 18992277)
1. Method development and validation of an in vitro model of the effects of methylphenidate on membrane-associated synaptic vesicles. Volz TJ; Farnsworth SJ; Hanson GR; Fleckenstein AE J Neurosci Methods; 2009 Feb; 177(1):177-82. PubMed ID: 18992277 [TBL] [Abstract][Full Text] [Related]
2. Methylphenidate-induced alterations in synaptic vesicle trafficking and activity. Volz TJ; Farnsworth SJ; Hanson GR; Fleckenstein AE Ann N Y Acad Sci; 2008 Oct; 1139():285-90. PubMed ID: 18991873 [TBL] [Abstract][Full Text] [Related]
3. Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane-associated vesicles. Volz TJ; Farnsworth SJ; King JL; Riddle EL; Hanson GR; Fleckenstein AE J Pharmacol Exp Ther; 2007 Nov; 323(2):738-45. PubMed ID: 17693585 [TBL] [Abstract][Full Text] [Related]
4. Methylphenidate-induced increases in vesicular dopamine sequestration and dopamine release in the striatum: the role of muscarinic and dopamine D2 receptors. Volz TJ; Farnsworth SJ; Rowley SD; Hanson GR; Fleckenstein AE J Pharmacol Exp Ther; 2008 Oct; 327(1):161-7. PubMed ID: 18591219 [TBL] [Abstract][Full Text] [Related]
7. Measurement of kinetically resolved vesicular dopamine uptake and efflux using rotating disk electrode voltammetry. Volz TJ; Hanson GR; Fleckenstein AE J Neurosci Methods; 2006 Jul; 155(1):109-15. PubMed ID: 16480775 [TBL] [Abstract][Full Text] [Related]
8. Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain. Easton N; Steward C; Marshall F; Fone K; Marsden C Neuropharmacology; 2007 Feb; 52(2):405-14. PubMed ID: 17020775 [TBL] [Abstract][Full Text] [Related]
9. Acrylamide inhibits dopamine uptake in rat striatal synaptic vesicles. LoPachin RM; Barber DS; He D; Das S Toxicol Sci; 2006 Jan; 89(1):224-34. PubMed ID: 16207938 [TBL] [Abstract][Full Text] [Related]
10. Cocaine alters vesicular dopamine sequestration and potassium-stimulated dopamine release: the role of D2 receptor activation. Farnsworth SJ; Volz TJ; Hanson GR; Fleckenstein AE J Pharmacol Exp Ther; 2009 Mar; 328(3):807-12. PubMed ID: 19038779 [TBL] [Abstract][Full Text] [Related]
14. Action potentials and amphetamine release antipsychotic drug from dopamine neuron synaptic VMAT vesicles. Tucker KR; Block ER; Levitan ES Proc Natl Acad Sci U S A; 2015 Aug; 112(32):E4485-94. PubMed ID: 26216995 [TBL] [Abstract][Full Text] [Related]
15. Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants. Brown JM; Hanson GR; Fleckenstein AE J Pharmacol Exp Ther; 2001 Mar; 296(3):762-7. PubMed ID: 11181904 [TBL] [Abstract][Full Text] [Related]
16. Methylphenidate alters basal ganglia neurotensin systems through dopaminergic mechanisms: a comparison with cocaine treatment. Alburges ME; Hoonakker AJ; Horner KA; Fleckenstein AE; Hanson GR J Neurochem; 2011 May; 117(3):470-8. PubMed ID: 21323925 [TBL] [Abstract][Full Text] [Related]
17. Cocaine-induced increases in vesicular dopamine uptake: role of dopamine receptors. Brown JM; Hanson GR; Fleckenstein AE J Pharmacol Exp Ther; 2001 Sep; 298(3):1150-3. PubMed ID: 11504813 [TBL] [Abstract][Full Text] [Related]
18. Alteration of dopamine uptake into rat striatal vesicles and synaptosomes caused by an in vitro exposure to atrazine and some of its metabolites. Hossain MM; Filipov NM Toxicology; 2008 Jun; 248(1):52-8. PubMed ID: 18423833 [TBL] [Abstract][Full Text] [Related]
19. HIV-1 Tat protein decreases dopamine transporter cell surface expression and vesicular monoamine transporter-2 function in rat striatal synaptosomes. Midde NM; Gomez AM; Zhu J J Neuroimmune Pharmacol; 2012 Sep; 7(3):629-39. PubMed ID: 22570010 [TBL] [Abstract][Full Text] [Related]